CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 4 Open-market buy Director bought 3,200 shares at $6.07 ($19,411)
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Grant or award CHIEF MEDICAL OFFICER acquired 39,000 shares (grant or award)
- 4 Grant or award EVP & CHIEF SCIENTIFIC OFFICER acquired 39,000 shares (grant or award)
- 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 2,593 shares at $5.53 ($14,339)
- 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 2,604 shares at $5.51 ($14,348)
- 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 1,951 shares at $5.48 ($10,691)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
Page 12 of 27 · 524 filings